FOCAL POINTS (Courageous Discourse)

FOCAL POINTS (Courageous Discourse)

Share this post

FOCAL POINTS (Courageous Discourse)
FOCAL POINTS (Courageous Discourse)
BREAKING--Infant Mortality Concern Emerges with Nirsevimab RSV Monoclonal Antibody Given to Newborns
Copy link
Facebook
Email
Notes
More

BREAKING--Infant Mortality Concern Emerges…

Peter A. McCullough, MD, MPH
Dec 27, 2023
199

Share this post

FOCAL POINTS (Courageous Discourse)
FOCAL POINTS (Courageous Discourse)
BREAKING--Infant Mortality Concern Emerges with Nirsevimab RSV Monoclonal Antibody Given to Newborns
Copy link
Facebook
Email
Notes
More
21
22

This thread is only visible to paid subscribers of FOCAL POINTS (Courageous Discourse)

Subscribe to view →

Listen to this episode with a 7-day free trial

Subscribe to FOCAL POINTS (Courageous Discourse) to listen to this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Peter McCullough MD MPH
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More